risperidone has been researched along with colforsin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Griffon, N; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
Fukunaga, K; Takeuchi, Y | 1 |
Akam, E; Strange, PG | 1 |
Choi, JH; Kim, SH; Lee, JS; Nam, JH; Son, H; Yang, BH | 1 |
Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
Klein, MT; Knight, J; Smith, C; Teitler, M; Toohey, N | 1 |
7 other study(ies) available for risperidone and colforsin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; DNA Replication; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Glioma; Haloperidol; Humans; Hybrid Cells; Naphthalenes; Neuroblastoma; Pertussis Toxin; Phenothiazines; Pimozide; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Risperidone; Salicylamides; Second Messenger Systems; Sulpiride; Tetrahydronaphthalenes; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1996 |
Different effects of five dopamine receptor subtypes on nuclear factor-kappaB activity in NG108-15 cells and mouse brain.
Topics: Animals; Antipsychotic Agents; Brain; Cell Line; Colforsin; DNA; Dopamine Antagonists; Electrophoretic Mobility Shift Assay; Frontal Lobe; Gene Expression Regulation; Haloperidol; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Protein Binding; Rats; Receptors, Dopamine; Risperidone | 2004 |
Inverse agonist properties of atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Butaclamol; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; Drug Interactions; Female; Humans; Receptors, Dopamine D2; Risperidone; Sodium | 2004 |
Phosphorylation of ERK and CREB in cultured hippocampal neurons after haloperidol and risperidone administration.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Cells, Cultured; Colforsin; Cyclic AMP Response Element-Binding Protein; Haloperidol; Hippocampus; Immunohistochemistry; Mitogen-Activated Protein Kinases; Neurons; Phosphorylation; Rats; Risperidone | 2004 |
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Cell Line; Colforsin; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Receptors, Serotonin; Risperidone; Serotonin Antagonists | 2009 |